Targeted drug offers 'landmark moment' in treatment of advanced breast cancer

New breast cancer drug hailed as 'landmark' moment in treatment of advanced disease

Around 8,000 women in the UK could benefit from the treatment, which can stall disease for twice as long as previous medicines

Scientists hail ‘landmark moment’ with new treatment for advanced breast cancer

A “landmark moment” in the treatment of advanced breast cancer could benefit thousands of women each year, scientists have said.

Pausing breast cancer treatment for pregnancy appears safe

Young women diagnosed with breast cancer often must delay pregnancy for years while they take hormone-blocking pills. A reassuring new study finds they can take a two-year break from these drugs to get pregnant without raising their short-term risk of cancer coming back. “This is really good news for young women and their doctors and…

Targeted drug offers 'landmark moment' in treatment of advanced breast cancer

The latest clinical trial using a new targeted drug - capivasertib - alongside hormone therapy suggests the combination could become the new treatment for patients with advanced forms of the most common type of breast cancer.

Capivasertib: Scientists hail ‘landmark moment’ as drug slows growth of breast cancer

New drug shown to shrink tumours in nearly a quarter of patients

‘Landmark’ breast cancer drug could save thousands of lives each year

‘The treatment is far less debilitating than chemotherapy and I’ve been given the gift of a longer life,’ says one patient